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Abstract
HUMAN LUNG TRYPTASE 
PURIFICATION AND CHARACTERIZATION 
by
Timothy J. Smith
Human lung tryptase (HLT), a mast cell derived trypsin-like enzyme, 
was isolated from whole human lung tissue obtained at autopsy.
Increased yieldB from this purification process allowed extensive 
characterization of the enzyme. One of the critical steps in the 
purification scheme was the use of a linear heparin gradient to elute 
active material from cellulose phosphate. Gel filtration studies in 1.0 
M NaCl yielded an apparent Mr of 135,000, and subsequent electrophoresis 
on sodium dodecyl sulfate-polyacrylamlde gels demonstrated the presence 
of two active species with apparent Mr “ 30,900 and 31,600. Enzymatic 
activity was sensitive to NaCl concentrations above 0.05 M and was only 
50% in 0.15 M NaCl, decreasing to 18% in 0.6 M  NaCl. The effects of 
synthetic and natural inhibitors were studied, confirming the enzyme's 
trypsin-like characteristics and demonstrating that naturally occurring 
serum inhibitors are Incapable of diminishing its activity. A complete 
amino acid analysis showed a high tryptophan content. Antisera to human 
lung tryptase was generated, and the immunological identity of active 
fractions was investigated. The stability of HLT in various buffer 
systems was extensively studied, and 10 mM MES buffer, pH 6.1 appeared 
to provide the best conditions during extended storage and purification. 
The effect of heparin on the enzyme's activity using the synthetic 
substrates Z-Lys-SBzl was studied, and heparin concentrations of 10 
micromolar stabilized HLT and allowed full expression of activity even 
at low ionic strengths. In the presence of heparin the enzyme retained 
full activity after 24 hours at 37°C, whereas in the absence of heparin, 
activity was lost after 30 mln at this temperature. Heparin had a 
similar effect on HLT's ability to cleave natural substrates such as 
flbronectin. Assays comparing the activity of HLT on the substrates 
Z-Lys-SBzl and Z-Arg-SBzl were performed. The and V m a v  of HLT for 
the above substrates were determined. The substrate 
4-methylumbelllferyl-p-guanldlnobenzoate (MUG-B) has been used to 
perform an active site titration on HLT, and a k of 610/sec was 
calculated for the substrate Z-Arg-SBzl. ca
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CHAPTER 1 
Introduction
Tissue protelnases may be Involved In a variety of disease 
processes and biological functions Including anglogenesls, 
fertilization, endocytosis, exocytosls, protein turnover, tissue 
degeneration, the Immune response and inflammation (Woodbury and 
Neurath, 1980; Starkey, 1977). The role of the neutrophil protelnases, 
elastase and cathepsin G In diseases such as arthritis and emphysema has 
been well studied (reviewed by Starkey, 1977). However, the 
physiological role of some other tissue proteinaBes has not been so 
clearly elucidated. Such is the case with the trypsin-like tissue 
protelnases referred to as tryptases.
Glenner and Cohen (1960) were the first to recognize trypsin-llke 
activity in human mast cells, and Johnson and Pascual (1978) noted 
tryptic activity in the high salt extracts of lung tissue. This 
activity seemed different from that of previously characterized tissue 
protelnases (Johnson, 1981). There have been reports of similar enzymes 
from skin (Fraki and Hopsu-Havu, 1975) and uterine cervix (Ito et el., 
1980). It is now thought that these tryptases are all of mast cell 
origin and may represent the same enzyme (Tanaka et al., 1983).
Schwartz et al. (1981a) successfully purified what has been called 
human lung tryptase (HLT) from purified mast cell preparations. 
Unfortunately, general application of this method was hindered by the 
requirement for very fresh tissue, the isolation of mast cells and 
yields of only microgram quantities of pure enzyme. Preliminary
research in our laboratory had already indicated that by beginning with 
whole human lung obtained at autopsy, milligram quantities of HLT could 
be generated (Johnson, 1980 unpublished data), but complete purification 
of the enzyme was not yet possible. A continuation of efforts to purify 
larger quantities of enzyme subsequently resulted in a unique 
purification scheme, a complete characterization Including physical and 
kinetic data, and raising antlBera to HLT. Therefore, a major 
contribution to the understanding of mast cell function and tissue 
protelnases has been made.
In order to provide a foundation on which to base a discussion of 
human lung tryptase, a brief review of protelnases Including definition, 
binding site specificity, limited proteolysis, types of protelnases, 
proteinase inhibitors and pathology has been included.
Definition of a Proteinase 
Protelnases are enzymes capable of catalyzing the hydrolysis of 
peptide bonds (Figure 1). When these cleavages are Internal in relation 
to the substrate, the proteinase is defined as an endopeptidase versus 
an exopeptidase which exerts its effect at a terminal peptide bond. An 
exopeptidase can be further defined by the position of the susceptible 
amide linkage as being either an amlnopeptidase or carboxypeptldase 
(Figure 2).
Binding Site Specificity 
Figures 1 and 2 are simplifications suitable only for demonstration 
of susceptible sites of cleavage by different groups of protelnases.
The mechanism of action involved in the proteolytic digestion of
3Figure 1. Hydrolysis of a peptide bond by a proteinase.
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4Figure 2. Schematic demonstration of the action of general 
groups of protelnases.
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polypeptides revolves around more than enzyme specificity for a single 
amino acid residue. While the action of protelnases results in 
cleavages of proteins at certain specific sites, other amino acids 
surrounding the susceptible bond also contribute to specificity. Joseph 
Fruton (1975) described proteolysis as "a multipoint cooperative 
process". By convention, the amino acid residue which contributes the 
carbonyl carbons to the peptide bond preferentially cleaved by a 
proteinase is called FI, and those amino a d d s  to the left of PI are 
termed P2, P3, PA, etc. The residues to the right of the "scissile 
bond" are designated PI', P21, P 3 1, etc., and these amino acids are part 
of the "leaving group". Similarly, the enzyme contains a primary 
binding site (Si) and subsites to the left and right. The arrangement 
of these primary sites and subsites is represented in Figure 3. 
Substrates must enter a pocket where they are stabilized by noncovalent 
Interactions. The arrangement of amino acids within the binding pocket 
determines the size and nature of the substrate to be accommodated.
Since noncovalent forces are very weak, several interactions are needed 
in order to stabilize the enzyme-substrate complex ([E-S]), i.e. if 
amino acids at the primary binding site and those surrounding the PI do 
not have the correct size, shape and charge, there will be no [E-S].
Some protelnases demonstrate a very narrow range of specificity. 
Thrombin, which is responsible for the conversion of fibrinogen to 
fibrin, is one such example. On the other hand, proteolytic enzymes 
such as pepsin or chymotrypsin show specificity for a wide range of 
substrates. Specificity rests within the binding site of the enzyme.
6Figure 3. Arrangement of primary binding sites and subsites. 
Arrow indicates primary cleavage site. P j-P'j cleavage is at the 
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More chan one protein or peptide may possess the correct geometric 
complementarity necessary to act as a substrate (Walsh, 1979).
Limited Proteolysis 
The action of proteolytic enzymes can be explained by discussing 
their specificity, but their biological function cannot be understood 
without a description of limited proteolysis. In biological systems, 
digestion by protelnases does not proceed randomly. There are only 
certain areas on the surface of proteins which contain sites where 
proteolytic cleavages can take place. "Accessibility" is the key word 
in an explanation of the nature of this phenomenon. Due to the tertiary 
structure of proteins, only certain peptide bonds are accessible 
(exposed) to the action of peptidases, and proteolysis is therefore 
limited (Neurath, 1975). Examples of this are seen when zymogen 
activation occurs due to the hydrolysis of specific peptide bonds. 
Consider the enzyme chymotrypsln. It is produced by pancreatic cells as 
the zymogen, chymotrypsinogen, and is secreted into the intestine. Once 
in the intestine it is converted to chymotrypsln by the action of 
trypsin. More specifically, trypsin, which has a preference for Lys-X 
or Arg-X residues, cleaves at only two such sites on chymotrypsinogen 
leading to the formation of active enzyme. Because of the tertiary 
structure of proteins, certain Bites within a molecule may be more or 
less accessible to digestion by protelnases. Thus, the folding of the 
polypeptide chain can be viewed as an important control mechanism in 
limited proteolysis (Blackburn, 1976; Walsh, 1979). It was previously 
noted that chymotrypsln shows broad specificity. There are examples of
more specific limited proteolysis. Kalllkriens, which convert klninogen 
to kinins, show such a high degree of specificity that they have little 
or no activity on other proteins. A  Blmilar situation is seen with the 
conversion of anglotenslnogen to angiotensin I and II (Pisano, 1975).
In addition, the blood clotting cascade involves a series of specific 
zymogen activations. The activated products of limited proteolysis 
serve to activate, in sequence, the next step in the cascade (Stryer,
1975).
As a research tool, the controlled digestion of native proteins has 
been used extensively to compare the action of different protelnases. 
Alternatively, a protein of interest could be subjected to denaturing 
conditions. This renders amino acids or sequences of amino acids which 
would normally be "hidden", susceptible to "complete proteolysis". Thus 
time and the sequence of amino acids around PI, not tertiary structure, 
become the factors controlling the rate of cleavage. Protelnases 
Involved in the breakdown of dietary products and in intracellular 
protein catabolism offer examples of complete proteolysis in vivo. 
General proteolytic digestion results in the cleavage of all susceptible 
peptide bonds, whereas limited proteolysis leads to the hydrolysis of 
only accessible sites.
Proteinase Classification
In 1960, a convenient and abbreviated method for classifying 
proteases was proposed. While the classification neglected their 
biological function, it successfully grouped the protelnases into four 
distinct categories based on their catalytic mechanisms (Table I). This
was an Improvement over nomenclature which until that point had been 
based entirely on origin or physiological role and substrate specificity 
(Walsh, 1975).
Serine protelnases
The serine protelnases, which are also referred to as hydroxyl or 
neutral protelnases, have pH optima around 7.0, and possess a reactive 
serine within their active site. Common features of this group of 
protelnaseB include the following: (1) inhibition by 
dilsopropylphosphofluorldate (DIPF), (2) similarities in catalytic 
mechanism (formation of a tetrahedral intermediate), (3) secretion as 
zymogens, (4) amino acid sequence similarities, (5) endopeptidase 
activity and (6) presence of a "charge relay" system (Walsh, 1979; 
Fersht, 1977). Their crucial differences lie in their specificities, 
which are related to the sequence of amino acids in their binding sites 
(Walsh, 1979) and their individual biological functions.
The enzymes, trypsin, chymotrypsin, and elastase provide the best 
examples of this group of protelnases. Trypsin, which has a preference 
for the carboxyl side of Lys and Arg residues, contains an Asp at 
position 189 in the binding pocket. There is a Ser at position 189 
within the binding pocket of chymotrypsin and elastase. The difference 
in specificity between chymotrypsin and elastase is related to the amino 
acids at positions 216 and 226. In elastase they are Val and Thr, 
respectively, so the preferred substrates contain small uncharged side 
chains. With chymotrypsin and trypsin, positions 216 and 226 are 
occupied by Gly residues. Thus, chymotrypsin can accommodate large
10
Class
Serine Proteinase
Sulfhydryl Proteinase
Metalloprotelnase
Acid proteinase
Table I
Classification of Protelnases
Important 
Feature of 
Active Site
Serine 
Cysteine 
Zinc 
Aspartic Acid
Inhibitor
DIPF
Iodoacetate
o-phenanthroline
Dlazoketones
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hydrophobic amino acids (Price and Stevens, 1982). Figure 4 
demonstrates the differences in the binding pockets of these three 
protelnases.
With the serine protelnases, the serine residue at position 195 is 
especially reactive. Jansen et al. (1949) showed that when 
radiolabelled DIPF was Incubated with chymotrypsin the enzyme was 
irreversibly inactivated by what appeared to be a covalent modification. 
It was later established that substrates could protect chymotrypsin from 
DIPF inactivation, implying that the modification was active site 
directed (Jansen et al., 1950). The structure of DIPF and the 
phosphorylation of the active site serine at position 195 is 
seen in Figure 5. The reason for the enzyme inactivation became 
apparent after extensive studies using x-ray crystallography revealed 
the presence of a "charge relay" system made up of three precisely 
arranged side chains (Asp 102, His 57, and Ser 195) in the protein 
structure (Blow e£ al,, 1969). Figure 6 serves to illustrate the 
function of the "charge relay system" and the formation of the 
tetrahedral intermediate during catalysis.
Sulfhydryl protelnases
Cysteine or sulfhydryl protelnases contain a nucleophilic cysteine 
residue at their active site. The term thiol proteinase has also been 
used to describe these enzymes. They are endopeptidases, and an 
acylthloester intermediate is generated during catalysis. Cathepsin B 
is the best studied mammalian proteinase of the group; however, the 
ubiquity of this peptidase has been the cause of considerable difficulty
12
Figure 4. Important amino acid residues in the binding 
pockets of chymotrypsin* trypBln and elastase. Chymotrypsin 
contains Gly residues at positions 216 and 226 in order to 
accommodate large hydrophobic amino acids. In trypsin, position 
189 is an Asp which preferentially binds Lys and Arg side chains. 
Due to position 216 and 226 being occupied by Val and Thr in 
elastase, only small uncharged side chains are bound.
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Figure 5. The action of DIPF on a serine proteinase leading 
to phosphorylation of the active site serine at position 195. DIPF 
reacts with the critical Ser residue to form an inactive 
dllsopropylphosphoryl enzyme.
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Figure 6, The mechanism of action for a serine proteinase.
I. Catalysis begins with a nucleophillc attack of the Ser 195 
hydroxyl at the carboxyl of the substrate. The charge relay system 
is made up of Asp 102, His 57 and Ser 195. General acid-base 
catalysis facilitates the attack. II. The oxyanlon of the adduct 
is stabilized by hydrogen bonding to the amino group of Gly 193 and 
the Ser 195. III. The tetrahedral intermediate collapses via 
expulsion of the amine product which has become protonated from the 
N-3 of His 57 as it leaves. IV. Deacylation involves the reverse 
of acylatiDn. An attacking water molecule becomes a strong 
nucleophile because of proton shuttling on the catalytic triad. V. 
There is a formation of a new tetrahedral intermediate due to 
proton transfer with the charge relay system. VI. Formation of 
the E-P complex, from which the product dissociates.
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In the study of tissue thiol protelnases in general. Slight variations 
in substrate susceptibility and Isolation from many different tissues, 
often within the same species, has lead to confusion in the literature. 
"A major difficulty in the study of the tissue thiol protelnases is that 
of distinguishing them from each other" (Barrett, 1977).
There are Important sulfhydryl protelnases from sources other than 
mammalian tissue. It Is common practice to compare the mammalian and 
plant protelnases. There are many similarities In their activities and 
amino acid sequences, and enzymeB such as papain, flcin, and bromelain 
are probably earlier representatives in the evolutionary pathway leading 
toward mammalian cysteine protelnases (Vavreinova and Turkova, 1975).
For Instance, the amino terminus of rat liver cathepsln B shows 
extensive homology with that of papain (Takio, 1980).
It seems certain that thiol protelnases are Involved in 
intracellular protein catabolism. This is due to their presence within 
the lysosomes and the fact that there is a direct correlation between 
the rate of protein turnover and the activity of these enzymes (Barrett 
and Kirschke, 1980).
The classification of the protelnases in Table I shows that the 
sulfhydryl peptidases are inhibited by iodoacetamide, which reacts 
directly with the essential thiol group.
Metalloproteinases
These enzymes are classified into two separate categories, either 
metalloexopeptldases or metalloendopeptidases, and they are inhibited by 
o-phennnthroline, a zinc chelator. Both require stoichiometric
16
quantities of divalent cations for catalysis. Leucine aminopeptldase 
and carboxypeptldase A are perhaps the best examples of the 
exopeptidases of this category. Each is capable of sequential 
cleavage of amino acid residues beginning at their respective terminal 
sites.
Carboxypeptldase has been extensively studied. X-ray 
crystallography studies on the enzyme were completed in 1970 by Lipscomb 
et al,, and a mechanism of action has been proposed (Blackburnt 1976; 
Valsh, 1979). Its rate of catalysis is enhanced if the terminal group 
is a large aromatic or aliphatic amino acid and the divalent cation 
involved in the mechanism is zinc. Leucine aminopeptldase also has a 
preference for aromatic amino acids. Very little is known about this 
enzyme aside from its requirement for zinc and its molecular weight of 
300*000 daltons (DeLange and Smith, 1971).
Thermolysln, a metalloendopeptidase, has the same requirement for 
zinc, but it has a large hydrophobic pocket in its tertiary structure 
which is similar to that of chymotrypsin (Colman et al., 1972). Maximum 
catalysis is seen at acid pH; .for this reason we might consider it to be 
an acid proteinase, Thermolysln raises an interesting point concerning 
the classification of proteolytic enzymes which was best described by 
Kenneth Walsh. "We must avoid over confidence. While we do recognize 
five fundamental sets of proteases and have inklings about their 
mechanisms, the list of sets is surely not complete and exceptions to 
the apparent sets are already known" (Walsh, 1975). Yet another example 
of inconsistency is seen with what have been referred to as the calcium 
activated protelnases. It appears that these may all be classified as
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sulfhydryl protelnases due to the fact that they are Inhibited by the 
common thiol proteinase Inhibitors.
Acid Protelnases
The aspartyl protelnases are all Inhibited by pepstatln which has 
little or no effect on other groups of protelnases (Knight and Barrett,
1976). Thus inhibition of a proteinase by pepstatln is Indication that 
it is an acid proteinase. Pepsin, one of the better studied acid 
protelnases, was discovered in 1834. It Is a gastric enzyme which 
functions to breakdown ingested protein and demonstrates its highest 
catalytic activity at pH 1-5. It Is secreted by the gastric mucosal 
cells in zymogen form (pepsinogen) and Is activated by autocatalytic 
limited proteolysis. The enzyme has endopeptidase activity and 
preferentially cleaves at aromatic and aliphatic amino acids (Fruton, 
1971; Tang, 1971; Clement, 1973).
Proteinase Inhibitors
There are many synthetic inhibitors of the protelnases, some of 
which have been mentioned above. Although discussion of these 
inhibitors is not relative to the subject, it should be mentioned that 
the use of synthetic inhibitors to study protelnases has been extremely 
valuable, especially in comparing protelnases and elucidation of active 
site conformation.
In biological systems, protelnases are often found in close 
proximity to tissues which might be excellent substrates (i.e. they are 
not always compartmentalized assuring the "safety" of surrounding
Table II
Circulating Plasma Proteinase Inhibitors
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Inhibitor Concentration mg/dl
a^Froteinase Inhibitor 125 - 135
ctjMacroglobulin
a2 Antiplasmln
190 - 320
djAntichymotrypsin 42 - 55
Inter-a-trypsin inhibitor 50 - 55
Antithrombin III 22 - 26
cT Inactivator 20 - 26
6 -  8
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tissue). In order to control protein digestion, naturally occurring 
proteinase Inhibitors have evolved. Table II contains a list of 
Inhibitors found In human plasma and their approximate concentrations. 
Any absence or decrease In the amount of these Important inhibitors can 
lead to random tissue destruction. Factors leading to an imbalance In 
the system of protelnases and their Inhibitors and the complications 
which arise from such an Imbalance are discussed below. For additional 
information on human plasma proteinase inhibitors the reader Is referred 
to two recent reviews (Laskowski and Ikunoshin, 1980; Travis and 
Salvesen, 1983).
Pathology
The pathophysiology of protelnases Is best understood If it is 
remembered that under normal conditions these enzymes remain either 
compartmentalized or controlled by the circulating plasma proteinase 
Inhibitors. If a situation arises wherein compartmentalized protelnaseB 
are released or there Is insufficient inhibitor for the control of 
proteolysis, tissue damage may ensue.
Above all other tissues and cells, the polymorphonuclear leukocyte 
(PMN) and its proteolytic enzymes have received the most attention in 
diseases involving uncontrolled proteolysis. This is not by chance. 
After all, it is this cell which is attracted via chemotactic stimuli to 
sites of inflammation and is sequestered in certain tissues with the 
physiological role of taking part in the inflammatory response.
The PMN is a granulated, phagocytic cell, and ingestion of material 
such as urate crystals, endotoxin, immune complexes and bacteria by the 
PMN have been shown to cause a "specific" release of serine protelnases
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such as elastase and cathepsin G from the azurophilic granules (Movat et 
al., 1973; Oronsky et al., 1973). The release Is specific in that there 
is no concomitant loss of cytoplasmic enzymes and the cells remain 
viable. Elastase and cathepsin G are capable of degrading a variety of 
tissues such as collagen, elastln, fibrin, proteoglycan and renal 
basement membrane (Janoff, 1972; Janoff and Blondin, 1973 and 1974). 
Starkey and Barrett (1976) showed that using cathepsin G and elastase, 
all of the major connective tissues could be hydrolyzed. Investigators 
speculate that several diseases Involving chronic inflammation such as 
arthritis, emphysema and extensive wound healing are complicated by the 
release of proteolytic enzymes from the PMN (Weismann et al., 1971; 
Glynn, 1972; Simpson and Ross, 1972; Oronsky et al,, 1973; Oronsky and 
Buermann, 1978).
In emphysema and respiratory distress Byndrome of the newborn, a 
genetically transmitted deficiency of alpha-l-protelnase inhibitor 
leaves the neutral protelnases of sequestered lung PMN's free to degrade 
the alveolar wall (Eriksson and Berven, 1972; Evans et al,, 1972). In 
other instances the amount of proteinase released from the PMN may be 
excessive and natural circulating Inhibitors may not be present in 
sufficient concentrations to inhibit proteolysis. This may be at least 
part of the problem in chronic inflammatory diseases such as arthritis 
and gout. In either case, phagocytosis of immune complexes or other 
material leads to the release of proteolytic enzymes and a 
"self-propagation" of the disease process.
Tissue protelnases have also been Implicated in degenerative 
diseases of the muscle such as muscular dystrophy and Ischemia (Schwartz
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and Bird, 1977). Some information regarding such an involvement seems 
quite convincing, since protelnases such as cathepsin B and D are known 
to be at higher levels in dystrophic muscle than In normal muscle 
(Spanler et al., 1977). McGowan et al. (1976) reported that leupeptln 
and pepstatln, inhibitors of these cathepsinB, were able to Inhibit the 
degeneration of muscle cells In culture.
Within recent years, the mast cell has been implicated in several 
diseases which are characterized by inflammation (reviewed in Wasserman, 
1984). Tryptase, which is a trypsin-like enzyme, and chymase, a 
chymotrypsln-like serine proteinase, are associated with the mast cell 
granule and could be involved in inflammation and localized tissue 
destruction. Thus it seems quite possible that they could be involved 
in uncontrolled pathoproteolysis similar to cathepsin G or elastase.
In concluding this section on pathology, one observation would seem 
appropriate. By nature, protelnases are capable of digesting protein 
substrates, however, we must be cautious in assigning pathological roles 
to these enzymes without first investigating the feasibility of such an 
involvement. In our haste to assign such a function, it is possible to 
neglect understanding the proteinase in its normal physiological role.
The Proteolytic Enzymes of Mast Cells 
Mast cells are large (10-30 pm), granule laden cells associated 
with the perivascular and perilymphatic spaces and are found in loose 
connective tissue and mucosal tissue in a variety of locations including 
skin, bladder, tongue, synovia, mesentery, and lung. The granules of 
the cell have a characteristic metachromasla when stained with basic 
dyes such as toluldine blue. This metachromatic staining has been
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attributed to their proteoglycan content. Since the discovery of the 
mast cell in the 19th century, research has focused on the staining 
characteristics of the cell and its involvement in anaphylaxis. The 
membrane bound granules, which contain mediators of anaphylaxis such as 
biogenic amines, proteoglycans, neutral protelnases, acid hydrolases, 
oxidative enzymes, chemotactlc factors, generated mediators of 
anaphylaxis and leukotrlenes give the cell its true individuality. 
Degranulation of these cells produce the effects of immediate 
hypersensitivity and anaphylactic shock. The mechanism for this 
Involvement in the allergic phenomenon has been firmly established. In 
brief, the mast cell contains on its surface specific receptors for IgE. 
After binding to these receptors via the Fc portion of the 
immunoglobulin, the antigen binding sites of two IgE molecules are 
dlmerlzed by specific antigen. This dlmerlzatlon leads to degranulation 
of the cell and the consequences of hypersensitivity or anaphylaxis.
For an excellent review of the morphology and chemistry of the mast cell 
see Ishlzaka (1984).
The morphology of mast cells may vary depending on the site of 
origin (Pearce et al., 1977), and evidence would Indicate that there may 
be two populations of mast cells (Patterson et al., 1977; Woodbury et 
al., 1978; Seppa and Jarvinen, 1978; Woodbury and Neurath, 1978; 
Patterson and Suszko, 1980). These populations have been termed 
"typical" and "atypical" mast cells (Schwartz and Austen, 1981). In 
addition, mast cells contain neutral protelnases which show variation 
among and within species (Chiu and Lagunoff, 1972; Woodbury et al., 
1981).
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In rats, the predominant serine proteinase, comprising 50Z of the 
granule protein and as much as 23% of the total cellular protein 
(Schwartz and Austen, 1981), is a chymotrypsin-like enzyme (chymase). 
chymotryptic activity was first reported in association with the rat 
mast cell in 1953 by a hlstochemlcal technique using
3-chloracetoxy-2~naphthoic acid anilide as substrate (Gomorl, G . , 1953). 
It is found bound to heparin, forming part of the granule matrix, and 
1.0 H KC1 is capable of eluting the chymase from other proteins 
(Lagunoff and Prltzel, 1976). Two forms of rat mast cell chymase have 
been found; each is associated with a particular type of tissue and mast 
cell type. Rat mast cell proteinase I (RMCP-I) is associated with 
connective tissue and is found predominantly in the typical mast cell. 
RMCP II is located primarily in mucosal tissue within the atypical mast 
cell (Woodbury et al., 1961). Although the amino acid sequences of the 
chymases are 75Z homologous in their first 51 N-terminal amino acids, 
the two protelnases show no immunological cross reactivity (Woodbury et 
al., 1978), suggesting distinct genetic origins.
The biological function of rat mast cell chymase remains obscure. 
The enzyme is not in zymogen form inBide the mast cell, but its strong 
binding to heparin (and possibly serotonin) and the internal pH of the 
mast cell granule may keep it relatively inactive (Yurt and Austen,
1977; Okuno-Kaneda et al., 1980). Once degranulation occurs, the 
heparin-chymase complex may persist, and the pH of the external medium 
may be more suitable for the complete expression of activity (Schwartz 
and Austen, 1984).
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There has also been some tryptase activity associated with the mast 
cell of the rat. Tryptase Is not considered a major component of this 
cell because the activity Is at the lower limit of sensitivity using the 
TAMe-esterase assay (Schwartz and Austen, 1981). Trypsln-like activity 
In human lung mast cells on the other hand Is at levels which compare to
that of chymase activity In rats. Human lung tryptase has been 
estimated to comprise 23% of the total protein of the human mast cell.
It Is thought to exist as a tetxamer with a molecular weight of 144,000 
daltons, demonstrating two active subunits at 37,000 and 35,000 daltons. 
It Is Interesting to speculate that these active subunits may represent 
two tryptases analogous to the RMCP I and RMCP II of rat lung tissue.
It seems likely that RMCP and tryptase are enzymes with similar
functions from the mast cells of different species. In addition, it has
been shown that tryptase has a strong affinity for heparin. The 
biological function of the mast cell tryptase Is also unknown. Several 
pieces of Interesting Information have surfaced In recent years 
concerning both chymase and tryptase. It Is possible that they play a 
role In the inflammatory response, but whether this role Is 
Intracellular, extracellular or both remains to be shown. Meier et al. 
(1983) demonstrated that a group of lung mast cell protelnases were 
capable of interacting with three proteins of the Hagamen Factor 
dependent pathways, prekallikrein, Hagamen Factor and klninogen.
Schwartz et al. (1982) showed that mast cell tryptase could cleave to
generate C^a anaphylatoxin. Due to the amount of tryptase required for 
cleavage and the Inability of the enzyme to cleave In the presence of
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heparin, assigning this as a biological function of HLT seems 
Inappropriate.
Dog mast cells contain tryptase, which has been shown to activate 
callagenase from fibroblasts (Blrkedal-Hansen et al., 1976), Yoffe et 
al. (1984) demonstrated that collagenase production increased in 
rheumatoid synovial cells with the addition of dog maBt cell extracts. 
Therefore, tryptase may be involved in pathoproteolysis. Supporting 
this, Vartlo et al. (1981) demonstrated that rat mast cell chymase was 
capable of cleaving fibronectin in a fashion similar to cathepsin G. 
Fibronectin functions in vivo to promote cell adherence to the 
extracellular matrix (Klebe, 1974; Fearlstein, 1976; Pearlstein and 
Gold, 1978).
Mast cells are located in connective and mucosal tissue, at the 
ends of new blood vessels, around neural tissue and the airways of the 
respiratory system. Their numbers have been shown to Increase during 
anglogenesis (Kessler et al., 1976) and inflammation in diseases such as 
arthritis (Sagreiya et al., 1983; Crisp et al., 1984; Godfrey et al., 
1984; Vasserman, 1984). The possible role of mast cell tryptase in 
Inflammation and anglogenesis will be discussed, however, tryptase could 
play a role in the inflammatory process similar to a degree equal that 
of elastase and cathepsin G.
Although the mast cell is not phagocytic, at least to the degree of 
the PMN, observed endocytosis using a variety of materials has shown 
that virtually all endocytlzed material becomes associated with the mast 
cell granule (Padewar, 1979). It has been shown that endocytlzed IgE is
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transferred from the cytoplasmic surface to the granule in as little as 
one hour after passive sensitization of the cell (Halliwell, 1973). 
Active tryptase associated with the mast cell granule may function to 
either process or degrade endocytlzed proteins such as IgE.
Additional comments concerning the biological activity of tryptase 
will be reserved for the discussion, due to the fact that this research 
contributes information which is useful in understanding the enzyme's 
function. We have successfully purified HLT from whole lung tissue, and 
an extensive characterization has been made possible. Antibody to the 
purified enzyme was made to be used in the subcellular localization of 
the enzyme and the development of an immunoassay. In addition, the 
effects of HLT on natural substrates such as fibronectin and IgE and the 
role of heparin in stabilization of the enzyme have been studied. The 
goal of this research was to contribute information which might be 
valuable in understanding the function of the mast cell.
CHAPTER 2 
MATERIALS
Octyl-Sepharose, cellulose phosphate, 2-(N-tnorphollno)ethane
sulfonic acid (MES), molecular weight electrophoresis standards, Trls,
Bz-DL-Arg-p-nitroanilide (Bz-Arg-NA), heparin, tosyl-L-arginlne methyl
ester, (TAMe), azocasein, benzamldine, 4-methylumbelllferyl p-quanidina-
benzoate, glycine, 3,3'-dlamlnobenzldine, ammonium sulfate, soybean
trypsin Inhibitor, lima bean trypsin Inhibitor, tosyl-L-Lys-chloromethyl
ketone, (TLCK), tosyl-L-Phe-chloromethyl ketone (TPCK), ovoinhibitor,
and p-chloromercurlbenzoate (p-CMB) were obtained from Sigma Chemical
Co. Dlisopropylphosphofluoridate (DIPP) was the product of Aldrich
Chemical Co. "Enllghtln" and [ H]-dlisopropylphosphofluoridate were
purchased from New England Nuclear. Acrylamlde and other chemicals for
electrophoresis were from Bio-Rad. Fractogel TSK-HW 55 was purchased
from MCB. The standards for gel filtration molecular weight
determination were from Pharmacia, Human alpha-l-proteinase inhibitor
was prepared as previously described (Travis and Johnson, 1981). Human
alpha-2-macroglobulln was a gift from Drs. J. Travis and G. Salveson,
(R)
University of Georgia. Trasylol ' bovine pancreatic trypsin inhibitor 
was a gift of Bayer A. G . , West Germany. Bronchial inhibitor (bronchial 
leucocyte protelnaBe Inhibitor) was isolated by the method of Smith and 
Johnson, 1985. Proteinase Inhibitors originally isolated by H. Umezawa 
(Aoyagl and Umezawa, 1975) which included antipain, chymostatin, 
elastinal, leupeptln, pepstatln, and phosphoramidon were provided by the 
U.S.-Japan Cooperative Cancer Research Program through Dr. W. Troll,
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N.Y.U. Proteinase Nexln I was from Dr. Joffe Bake, University of 
Kansas. Fibronectin was obtained from Calblochem-Behrlng. All other 
chemicals were of reagent grade or equivalent quality.
CHAPTER 3 
METHODS
Enzyme Assays
Activity was monitored using the substrate Benzyl-Arg-p- 
nitrosnilide (Bz-Arg-NA) (Erlanger et al*, 1961). One unit of activity 
was defined as the amount of enzyme which gave a change of 1,0 
absorbance units/min at 410 nanometers. HLT, diluted as necessary, was 
added to 2.85 ml of 0.1 M  Tris-HCl, 1 M glycerol, pH 8.0, and the assays 
were started with the addition of 50 microliters of 20 mM substrate in 
DMS0. After 30 min incubation at 37°C, the assays were stopped with the 
addition of 50 microliters of glacial acetic acid, and the absorbance 
was read on a Beckman Model 35 spectrophotometer. In order to compare 
specific activities, TAMe assays were performed as described by Schwartz 
et al. (1981a). Azocasein assays according to Barrett (1977) were used 
to test the effect of alpha-2~macroglobulin on the enzyme.
Stability studies and kinetic data were obtained using the 
substrates CBZ-Lys-thlobenzyl ester and CBZ-Arg-thiobenzyl ester. When 
saturating levels of substrate were Indicated, the two substrates were 
dissolved in DMSO at [S] of 20 mM. One ml assays were typically 
performed by adding 20 microliters of substrate, 890 microliters of 
0.1 M HEPES buffer which was 1.0 M  in glycerol, 10% DMSO and pH 7.5, 80 
microliters of 2 mM DTNB dissolved in the HEPES buffer and 10 
microliters of enzyme diluted as necessary. The 410 nanometer 
absorbance change was monitored for 2 min on a Cary 219 
Spectophotometer and converted to A^^/mln.
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The moles of enzyme active sites per mole of enzyme pooled from the 
cellulose phosphate peak were determined using the substrate
4-methylumbelliferyl-p-guanldinobenzoate (MUG-B) as described by Jameson 
et al. (1973). One ml assays were set up using 20 microliters of 
substrate, 50 to 150 microliters of enzyme, and 0.1 M barbiturate 
buffer, pH 8.3, added as necessary to give 1.0 ml. Blanks were included 
using 10 mM MES, pH 6.1, and 0.02% sodium azlde in place of enzyme. 
Fluorescent activity was measured on a Gilson Spectro Glo Fluorometer 
using an excitation filter of 330-400 nanometers and an emission filter 
of 400 nanometers. The fluorometer was set to read 0.000 units with the 
barbiturate buffer and 1.000 with a 1,0 mM quinine sulfate standard in 
the same buffer. Enzyme activity was measured as mlcromolar 4-methyl 
coumarin generated by comparing fluorescent units generated to a 
standard curve of fluorescent units v s . mlcromolar 4-MU. The micromoles 
of 4-MU produced were equivalent to micromoles of HLT in the assay.
Lung Tissue
Lung tissue was obtained at autopsy. If the tissue was to be used 
Immediately, it was refrigerated at 4°C. Material to be kept for future 
use was frozen at -20sC. Although some decrease in enzyme activity was 
noted with frozen as compared to unfrozen lung, freezing at this 
temperature provided a convenient method for storing large amounts of 
autopsled material for future use.
Enzyme Extraction
Unless specified all extraction steps were carried out at 4“C.
Five hundred grams of human lung was cut into small pieces (1.0 cm ) and
ground through a Climax meat grinder. A volume of water equivalent to 
the weight of the tissue was placed into a Haring blender, and the 
tissue was added. A  short blending cycle of 15-20 sec was carried out 
at low speed. The homogenate was then centrifuged at 5°C, 20,000 x g 
for 20 min. Following centrifugation, the pellet was again placed into 
the blender and homogenized with 500 ml of 10 mM MES, pH 6.1, 0.15 M in 
NaCl, 0.02% sodium azlde for 15 sec at low speed. This was followed by 
centrifugation as before. The blending and centrifugation steps were 
repeated a total of six times, until the supernatant fraction was free 
of hemoglobin and other soluble cellular components* The crude enzyme 
extract was prepared by homogenizing the pellet with 250 ml of 10 mM 
MES, pH 6.1, 2.0 M NaCl, 0.02% sodium azide at high speed for 1.0 min. 
Following homogenization, the preparation was centrifuged at 20,000 x g 
for 20 min. A total of three extractions were performed using the 2.0 M 
NaCl buffer. These supernatant fractions were pooled for further 
purification, and designated as "crude enzyme". The water and 0.15 M 
NaCl extracts contained blood and cellular proteins but only 13% of the 
total enzyme activity. Conversely, the 2.0 M NaCl extracts contained 
87% of the extractable HLT activity but very little hemoglobin or other 
blood proteins.
Ammonium Sulfate Fractionation 
Ammonium sulfate was slowly added to the pooled 2.0 M NaCl 
fractions at 4°C until a concentration of 2.0 M ammonium sulfate was 
reached, corresponding to approximately 45% saturation. The 
precipitated material was then removed by centrifugation at 5°C,
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20,000 x g for 90 min. The clear supernatant was decanted and brought 
to room temperature before chromatography on octyl-Sepharose.
Octyl-Sepharose Chromatography 
A 3.S x 22.5 cm column of octyl-Sepharose was equilibrated with 
10 mM MES, pH 6.1, 2.0 M NaCl, 0.022 sodium azlde, 2.0 M ammonium 
sulfate. The material from ammonium sulfate fractionation (600 ml) was 
allowed to load by gravity onto the column at room temperature.
Following this addition, the column was washed with equilibration buffer 
until the absorbance at 280 nanometers was less than 0.020. HLT was 
eluted from the column with 10 mM MES, pH 6.1, 0.022 sodium azide, 0.7 M 
NaCl, and 0.7 M  ammonium sulfate. Fractions (9.0 ml) were collected at 
a flow rate of 2.0 ml min, and active fractions were pooled for 
subsequent purification.
Dialysis
Three hundred ml of pooled material from the Octyl-Sepharose column 
was concentrated and dialyzed on an Amicon PM-30 membrane, at 4°C with 
10 mM MES, pH 6.1, 0.022 sodium azide, until the conductivity was 
equivalent to that of buffer containing 10 mM MES, pH 6.1, 0.022 sodium 
azlde, and 0.3 M NaCl.
Cellulose Phosphate 
Approximately 100 ml of dialyzed material was applied to a 1.5 x 
9.8 cm column of cellulose phosphate equilibrated with 10 mM MES, pH 
6.1, 0.3 M  NaCl and 0.022 sodium azlde. One ml fractions were collected 
at a flow rate of 10 ml/hr. Elution of the HLT was accomplished with a
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heparin gradient (0 to 22 mlcromolar) In 10 mM MES, pH 6.1, 0.3 M  NaCl, 
and 0.02Z sodium azide.
Heparin-Sepharose
Heparin was efficiently removed from HLT by the use of a heparin- 
Sepharose column (l.S x 15.0 cm) equilibrated with 10 mM MES, pH 6.1,
0.3 M  NaCl, and 0.02Z sodium azide. Material to be dehaparinized was 
added to the column and eluted with an NaCl gradient (0.3 to 1.0 M) in 
the above buffer. Four to ten ml of active HLT from the cellulose 
phosphate was commonly used for this column with excellent results. 
Active enzyme eluted from the heparln-Sepharose column was referred to 
as deheparinized HLT (D-HLT).
Electrophoresis
Electrophoretic analysis of reduced and unreduced SDS denatured 
protein was carried out on 1.5 mm, 12Z polyacrylamide gels aB described 
by Laemmll (1970), using a Bio-Rad Model 220 slab gel electrophoresis 
apparatus. A Bio-Rad 500 power supply was used starting at 15 mA (40 V) 
during stacking, changing to 25 mA constant amperage (70 V) after the 
tracking dye had entered the separation gel. Staining was accomplished 
with Coomassie brilliant blue in methanol, water and acetic acid 
(5:5:1). Destainlng was performed using methanol, water and acetic acid 
in the same proportions.
M f Determination
The apparent molecular weight of HLT was determined by 
chromatography on a 1.5 x 90 cm column of Fractogel TSK-HW 55 
equilibrated with 10 mM MES, pH 6.1, 1.0 M NaCl, 0.02Z sodium azide.
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Fractions of 1.0 ml were collected at a flow rate of 15.0 ml/hr. The 
molecular weights of the standard proteins were plotted against their 
K  , and the elution position of HLT relative to the standards was used
O
to estimate its apparent molecular weights. The proteins used to 
standardize the column were ferritin, aldolase and bovine serum albumin.
Log Mtf v s . was used to ascertain the molecular weight of the two 
forms of the enzyme seen on 12X  polyacrylamide electrophoresis gels.
The protein standards used for these estimates were bovine serum 
albumin, ovalbumin, carbonic anhydrase, trypslnogen and trypsin 
inhibitor.
pH Optima
The pH optimum for HLT activity was determined by measuring the 
hydrolysis rate of Bz-Arg-NA in buffers of various pH. The buffers, all 
50 mM, were: pH 3.0 and 4.0 sodium citrate; pH 5.0 sodium
citrate-phosphate; pH 6.0 and 7.0 sodium phosphate; pH 7.0 and 7.5 
Tris-phosphate; pH 8.0, 8.5, and 9.5 Trls-HCl; and pH 9.0 and 10.0 
sodium carbonate. The effect of pH on HLT stability was determined by 
pre-incubating the enzyme in 0.25 ml of the buffers listed above for 18 
hrs at 4"C prior to dilution with 2.7 ml of 0.1 M  Tris-HCl, 1.0 M 
glycerol, pH 8.0 for assay with Bz-Arg-NA. Data were normalized with 
the most active samples being taken as 100Z activity.
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Salt Effects
The effect of salt concentration was Investigated by assaying for 
Bz-Arg-NA activity In 0,1 M Tris-HCl buffer pH 8.0 containing 0.1 M,
0.15 M, 0.2 M, 0.3 M, 0.4 M and 0.6 M NaCl. The activity of the sample 
with no added NaCl was taken as 100% activity.
Amino Acid Analysis
Samples containing 0.0412 A2gg units of protein each from the gel 
filtration peak, which was free of heparin, were hydrolyzed in vacuo for 
12, 24, 48, and 72 hr with 6.0 N HC1 at 110eC, followed by duplicate 
analyses. The values for serine and threonine were obtained by 
extropalation to zero time. The 72 hr values were taken for valine and 
isoleuclne and the 24 and 48 hr data were averaged for the value of the 
other amino acids. The analysis of tryptophan was performed as 
described by Johnson (1983), after alkaline hydrolysis. Cysteine was 
determined as cystelc acid (Hlrs, 1967). The extinction coefficient was 
calculated from the recovery of amino acids relative to the 280
nanometers absorbance of the sample.
Fluorography
Selected fractions from each side and the middle of the activity
peak from cellulose phosphate elution were labeled with an excess of
[ H]-DIPF. Unbound label was removed by dialyses out and the protein
was subjected to electrophoresis and stained as described above. The
gel slab was submerged in "Enllghtln" for 15 min and then dried under
vacuum for approximately one hour. Positions of the standards were
14
carefully marked with a pen containing ( C]-toluene, and the dried slab
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was placed against Kodak SB-5 £iltn for 12 hr at -80°C, The developed
film was compared with a Coomassle blue stained gel to demonstrate 
3
[ H]-DIPF labeling of the stained protein bands. The apparent molecular 
weights of the HLT forms were estimated from a linear plot of log for 
standard proteins V£. R^ values.
Adherence of HLT to Glass Surfaces 
In order to determine if HLT adhered to glass, a dilution of active 
enzyme in 10 mM MES, pH 6.1, 0.1 M  NaCl was placed into two sets of 
glass tubes. One set was mixed gently end-over-end in order to make 
certain that the contents of the tube came In contact with the glass 
surface. The other set was allowed to stand following gentle swirling. 
Samples were removed from the tubes at 5.0, 15.0, 20.0, and 30.0 min and 
assayed using the substrate Z-Lys-SBzl. The percent activity remaining 
was plotted against time. One hundred percent activity was assumed to 
be the activity of the enzyme dilution before it was added to the tubes. 
The identical experiment was performed using polyethylene tubes and 
glass tubes with 100 ul of 5.0% polyoxyethylene-23-lauryl ether (Brij 
35), which is known to prevent protein adhesion to glass surfaces 
(Barrett, 1981).
Stabilization of HLT by Heparin 
Increasing amounts of heparin were added to separate assays 
containing 25 micrograras (0.39 micromolar) deheparinlzed HLT (D-HLT) and 
incubations were carried out for 24 hrs at 37aC after which 20 microliters 
of the contents of each tube were assayed using Z-Lys-SBzl. Percent 
activity remaining in each assay was related to the A ^ ^ / m l n  generated 
by a freshly made control containing D-HLT and 14,0 micromolar heparin.
37
Inactivation of H-HLT and D-HLT 
Inactivation studies on both K-HLT and D-HLT were performed at 25°C 
and 37°C. Two tubes containing either H-HLT or D-HLT were incubated at 
each temperature. One tube in each set contained 7.0 mlcromolar 
heparin, and the other tube contained HLT with no heparin. Assays were 
performed on 20 microllter samples from each tube at 5, 20, 45 and 60 
min using Z-Lys-SBzl substrate. One hundred percent activity waB 
assumed to be the A ^ g / m i n  of the sample with 7.0 micromolar heparin 
Incubated at 25°C, since had been previously shown that 7.0 mlcromolar 
heparin would completely protect the enzyme at this temperature (see 
below).
Inhibition Assays 
Inhibition of HLT waB studied by pre-lncubating various proteinase 
inhibitors with B.O micrograms of HLT for 15 min at room temperature in
1,0 ml of Tris-HCl buffer, pH 8.0. The samples were subsequently 
diluted to 2.85 ml and assayed using Bz-Arg-NA. Controls containing 
enzyme only were taken as 100% activity, and all other data were 
calculated relative to the controls. The inhibitors chosen and their 
concentrations are discussed in the results section.
Proteinase Nexin I 
Inhibition studies were carried out by using increasing 
concentrations of PN-I against a fixed concentration of HLT. The enzyme 
(7.0 nM) was Incubated 30 min with up to 188 nM PN-I in 0.1 M  HEPES pH 
7.5. After 30 min, assays were performed using the substrate 
Z-Lys-SBzl. The percent of activity remaining was based on a control 
containing only HLT.
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Determination of K and V 
____________________ m______ max
The K and V „„ for HLT using the substrates Z-Arg-SBzl and 
m  max
Z-Lys-SBzl were determined UBing a Lineweaver-Burke plot. Substrate
concentrations ranged from 1.25 mM to 20 mM. Plots of 1/v vs. 1/[S]
were then generated for the determination of K and V .
m max , .
Purification of Fibronectin 
Fibronectin was purified from human plasma by the method of Vuento 
and Vaherl (1979). While there were some contaminants present in our 
preparation, it was judged by electrophoresis to be of equal quality to 
commercially available fibronectin purchased from Calbiochem.
Fibronectin Digestion 
Fibronectin (30 micrograms) was incubated in the presence of 
increasing concentrations of HLT (3.0 micrograms, 6.0 micrograms and 12 
micrograms). Typical reaction mixtures contained 30 microliters of 
fibronectin, 50 to 200 mlcrollters of HLT and sufficient 0.1 M Tris-HCl 
pH 8.1 to bring the total volume to 500 microliters. After incubation 
at 37°C for 24 hr, proteolysis was stopped with the addition of 50 
microliters of 10Z SDS. Samples were then brought to 1 ml total volume 
with the addition of 500 microliters of water and dialyzed agalnBt 3 
changes of water at 4°C. After dialysis they were evaporated to dryness 
with a Buchler Evapomlx. Laemmli sample buffer (50 microliters) and 10 
microliters of 250 mM DTT were added and electrophoresis was carried out 
as described above.
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Immunological procedures 
Rabbit antisera to HLT was produced by intradermal injection of 200 
micrograms of HLT suspended in Freund’s complete adjuvant (1.0 ml total 
volume) at 10 sites on the animal's back. After two and four weeks the 
animal was given boosts containing 100 micrograms of HLT protein in 
Freund's incomplete adjuvant. Blood was obtained by cannulatlng the ear 
artery.
Immunodiffusion assays of the serum was performed according to 
Ouchterlony (1968). Each outside well contained 10 microliters of 
antigen. The center well contained 10 microliters of rabbit antisera to 
HLT. After Incubation for 24 hrs at 25°C, the plate was washed in 
phosphate buffered saline, and precipitates were stained with Coomassie 
blue.
CHAPTER 4 
RESULTS
Purification
Purification of HLT was performed on lung tissue which had been
frozen and stored at -20°C. Storing lung tissue at this temperature had
only a marginal effect on the total activity. All pulmonary tissue was 
judged to be grossly normal by the pathologist performing the autopsy, 
however, no distinction was made between smokers and nonsmokers.
Figure 7 shows the major steps in the purification scheme for HLT. 
The pH of 6.1 which is maintained throughout the purification procedure 
is the pH at which HLT is most stable and the internal pH of mast cell 
granules (Johnson et al., 1980). There is some solubilization of 
activity during the initial 0.15 M NaCl extraction steps, but the 
majority of the enzyme is not solubilized until the salt concentration 
is increased to 2.0 M.
Following the solublizatlon of the enzyme, the extract was made
2.0 H in ammonium sulfate as required for hydrophobic chromatography on
octyl-Sepharose (Fig. 8). A large amount of inactive material did not
bind to the octyl-Sepharose and considerable lipid remained bound to the 
column after the elution of HLT. A significant amount of activity was 
lost using this particular column. Recently, we used a chloroform 
extraction as a substitute for octyl Sepharose chromatography. By using 
an equal volume of crude enzyme and cold chloroform, a clear extract was 
produced which gave a 973! yield. This chloroform extraction will 
require additional study but initial results are promising.
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Figure 7. The major steps in the purification of human lung 
tryptase.
WHOLE HUMAN LUNG OBTAINED AT AUTOPSY
HOMOGENIZATION IN HjO
HOMOGENIZATION IN 10 mM MES, pH 6.1, 
0.15 M  NaCl, 0.022 NaN3 (X's 6)
EXTRACTION WITH 10 mM MES, pH 6.1, 2 M NaCl, 
0.022 NaN3 (X's 3)
t
AMMONIUM SULFATE FRACTIONATION
OCTYL SEPHAROSE
t
DIALYSIS
t
CELLULOSE PHOSPHATE (HEPARIN ELUTION)
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Figure 8. Elution pattern of 3.5 X  22.5 cm octyl-Sepharose 
column. Equilibration buffer 10 mM MES, pH 6.1, 2.0 m NaCl, 0.02% 
sodium azlde, 2.0 n  ammonium sulfate. Elution buffer same as above 
with 0.7 M NaCl and 0.7 M ammonium sulfate. Fractions of 9.0 ml
were collected at a flow rate of 2.0 ml/mln. --- , A2g0
concentration; o— — o, activity. Between points A and B the column 
was washed with 2.0 L of equilibration buffer. Chromatography was 
performed at 25°C.
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Figure 9. Elution pattern of cellulose phosphate column
chromatography: — , A28Q; o— o, activity; o o, linear heparin
gradient (0-22 mlcromolar, based on heparin MW of 10,000). Column 
was 1.5 X 9.8 cm, equilibrated with 10 mM MES, pH 6.1, 0.02% NaN^, 
0.3 M NaCl. Flow rate was 1 ml/min. Heparin gradient was made in 
above buffer. Chromatography was performed at 25°C.
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Active fractions from the octyl-Sepharose were dialyzed to reduce 
the salt concentration to 0,3 M  before applying to a column of cellulose 
phosphate (Fig. 9). Since considerable activity is lost by dialysis 
with membrane tubing, dialysis was performed using an Amlcon 
concentrator with a FM-30 membrane. The material was repeatedly 
concentrated and diluted with 10 mM MES, pH 6.1, 0.02% NaN^ until the 
conductivity matched that of 10 mM MES, pH 6.1, 0.3 M  NaCl. This 
resulted in 70 to 80% recovery of activity. Ct is Important to keep the 
enzyme in buffers of high ionic strength, because this reduces the 
chances of autolysis by suppressing HLT activity and decreases the 
tendency of the enzyme to bind to glass and plastics. The elution of 
HLT from cellulose phosphate with a heparin gradient demonstrates the 
high affinity of this enzyme for the acidic mucopolysaccharide. The HLT 
yield from the column was 13.8% with a concomitant 232-fold purification 
from the crude extract (Table III). From 500 g of lung, a total of 5.4 
Ajgg units were obtained. This equals 1.92 mg of protein based on an 
extinction coefficient of 28.1 for a 1% solution of the HLT.
Electrophoretic Analysis and Molecular Weight Determination
Electrophoretic analysis of the enzyme preparation at each step In 
the purification is shown in Fig. 10. Results of reduced and unreduced 
samples of HLT from the cellulose phosphate reveal a single area of 
protein, suggesting a homogeneous preparation. Due to overload, the two 
molecular weight forms of HLT are not apparent on this gel, but gels 
with less protein as well as the fluorographs (Fig. 11) showed two 
bands. Additionally, some separation of the two molecular weight forms
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TABLE III
Fractionation Data for Purification of HLT. 
Activity based on assays with Bz-Arg-NA
Vol Total Total Specific Purifi- 
Step ml. ^ g Q  Activity Activity cation X Yie
Crude Enzyme 500 7950 215 0.027 1 100
Octyl-Sepharose 395 1059 51.9 0.049 1.8 14.1
Cellulose Phosphate 37 5.4 33.9 6.27. 232.2 15.8
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Figure 10. The results of 12Z SDS-Polyacrylamide gel 
electrophoresis of HLT purification. Lane 1, crude enzyme; lane 2, 
octyl-Sepharose; lane 3, reduced HLT from pooled cellulose 
phosphate peak; lane 4 f unreduced HLT from pooled cellulose 
phosphate peak; lane 5, standards. Standards ore indicated by 
letters: A. bovine albumin (66,000); B. carbonic anhydrase
(29,000); C. trypsin inhibitor (20,100); D. a-lactalbumin (14,200). 
Fifty micrograms of protein was loaded in each well. Gels were 
stained with 5:5:1 Coomassie blue in methanol, water and acetic 
acid.
1 2 3 4 5
47
Figure 11. Results of 12% SDS-polyacrylamide gel 
electrophoresis (lanes 1, 2, 3. and 4) and fluorography (lane 2', 
3', and 4') of peak and side fractions from cellulose phosphate. 
Lane 1, standards; lane 2 and 2't fraction #80; lane 3 and 3', 
fraction #85; lane 4 and 4', fraction #95. Standards, indicated by 
letters A to F, are bovine albumin (66,000), egg albumin (63,000), . 
carbonic anhydrase (29,000), trypsinogen (23,000), trypsin 
inhibitor (20,100), and a-lactalburain (14,200) respectively.
Protein (30 micrograms) labeled with [^H]-DIPF (1.9 x lO^DPM) was 
loaded in lanes 2, 3, and 4, and lanes 2', 3', and 4' represent 
their respective fluorography after 12 hours at -80°C. The 
SDS-polyacrylamide gel electrophoresis was stained with 5:5:1 
Coomassie blue in methanol, water and acetic acid.
I
9
1
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of HLT was accomplished during chromatography on cellulose phosphate.
The front side of the cellulose phosphate activity peak was richer in 
the higher molecular weight form and the back side was enriched with 
respect to the lower molecular weight form. This separation is clearly 
visible in Fig. 11* lanes 2 and 4. Both species are active as evidenced 
by their reactivity with [3H]-DIPF (Fig. 11, lanes 2 1 and 4'). Using 
log MW vs. plots of standard proteins, the M^ , values of the two 
species were determined to be 31,600 and 30,900 (Fig. 12).
The apparent molecular weight of HLT was estimated by gel 
filtration to be 135,000 daltons in buffers containing 1.0 M NaCl (Fig. 
13). This apparent molecular weight may represent a tetramer, since two 
active species with molecular weight of 30,900 and 31,600 were observed 
upon SDS-polyacrylamide gel electrophoresis in the presence of reducing 
agents.
The percentage of active sites for the pooled cellulose phosphate
3
peak was estimated to be 69% based on incorporation of [ HJ-DIPF. This 
is comparable to the value of 58% obtained by spectrofluorometrlc 
titration using KUG-B.
Amino Acid Analysis
The amino acid composition of HLT is given in Table IV along with 
that calculated from the data of Schwartz et al. (1981b) for their 
preparation of this enzyme from purified lung mast cells. These data, 
when tested for relatedness as described by Coralsh-Bowden (1980) met 
the "strong test". The composition of anionic human trypsin (Mallory 
and Travis, 1973) was also compared to that of HLT, but this comparison
49
Figure. 12. Log MW vs. R^ for standards and HLT on 12Z SDS 
polyacrylamide electrophoresis gels showing of 31,600 and 30,900
for 2 species of HLT. Standards are A. bovine serum albumin
(67,000), B. ovalbumin (45,000), C. carbonic anhydrase (29,000), D.. 
trypslnogen (24,000), and E. trypsin Inhibitor (20,100). Protein 
concentration was 20 pg/lane.
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Figure 13. M r determination of HLT by gel filtration using 
Fractogel TSK-HW 55. Standards are A. ferritin (440,000), B. 
aldolase (158,000), and C. bovine serum albumin (66,000). Column 
size (1.5 X 90 cm). Buffer, 10 mM MES, pH 6.1, 0.02Z sodium azlde,
1.0 M  NaCl. Fractions of 1.0 ml were collected at a flow rate of
15.0 ml/hr.
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Table IV 
Amino Acid Composition of HLT
Amino
Acid Value HLT
Mast Cell 
Tryptase8
Human Anionic 
Trypsin
Asp 25.05 25 25 21
Thr 12.63 13 11 20
Ser 13.31 13 19 24
Glu 25.74 26 30 21
Pro 25.62 27 24 9
Gly 26.60 27 30 20
Ala 16.34 16 17 ■ 13
CyB 8.60 9 1 8
Val 25.02 25 20 16
Met 4.10 4 3 1
lie 11.94 12 8 12
Leu 25.66 26 21 12
Tyr 11.33 11 6 7
Phe 4.85 5 5 4
His 10.40 10 10 3
Lya 11.79 12 9 11
Arg 14.25 14 13 6
Trp 8.80 9 ND 3
Total 284 252 211
aData calculated from Schwartz et al. (1981a) 
From Malory and Travis (1973)
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failed even Che "weak test" for relatedneas. The 280 nanometer 
extinction coefficient of 28.1 for a 1% protein solution was calculated 
from the recovery of amino acids.
pH and Salt EffectB 
HLT demonstrated best activity at pH 7.5 to 8.0 but was most stable 
at pH 5.5 - 6.1 (Fig. 14). As previously noted, high NaCl 
concentrations inhibited HLT activity and aided in stabilizing the 
enzyme during storage. At 0.15 M  NaCl the enzyme was only 50Z active 
(Fig. 15).
Adherence to Glass 
The enzyme has a high affinity for glass surfaces. Polyethylene or 
polystyrene tubes and transfer devices and silicon treated glassware 
were found to be absolutely essential during the purification of HLT.
As much as 50% of the activity for HLT could be lost in as little as 30 
mln if stored or assayed in glass. High salt concentrations were found 
to Improve this situation somewhat.
Effects of Heparin on HLT 
At 25°C the effect of heparin on HLT appeared to be dose dependent 
until a critical concentration was reached. At this point additional 
heparin failed to Increase the activity of the enzyme. Deheparinized 
D-HLT at a concentration of 135 nanomolar required approximately
7.0 micromolar porcine heparin to reach a concentration where tryptase 
would remain 100% active during 1.0 hr incubations at 25°C in 0.1 M 
HEPES, pH 7.5 (Fig. 16). Assays using Z-Lys-SBzl were performed after 
the 1.0 hr preincubation as described previously. In order to see if
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Figure 14. pH profile for HLT. The stability (---) plot is
enzyme activity remaining after 18 hr at 4°C at the indicated pH. 
Assays were performed at pH 8.0, 25°C as described in Methods. The
activity (--- ) plot Is the activity of the enzyme assayed at the
indicated pH. Bz-Arg-NA was the substrate.
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Figure 15. Effect of NaCl 
activity remaining vs. M  NaCl. 
substrate Bz-Arg-NA at pH 8.0.
on human lung tryptase. Percent 
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Che apparent stabilization was due cotally to heparin, a total of four 
controls were performed with the experiment (Table V). An assay with 
fresh D-HLT was performed, representing 100% activity. Assays performed 
with 40 micromolar heparin yielded nearly 100% activity even after 
allowing the enzyme to preincubate 1.0 hr in the HGFES buffer. Another 
control in which 40 micromolar heparin was added after 30 mln 
preincubation yielded only 81% of the initial activity. A final control 
containing no heparin showed only 42% activity relative to fresh D-HLT 
or D-HLT plus heparin at zero time after Incubation for 1.0 hr.
An interesting observation was made when a solution of D-HLT 
containing 7.0 micromolar heparin and a solution containing only D-HLT 
were preincubated in 0.1 M  HEFES, pH 7.5 (Fig. 17). Assays performed at 
5.0, 20, 45, and 60 min demonstrated that D-HLT without heparin was 
rapidly Inactivated at both 25 and 37°C and enzyme which had 7.0 
micromolar heparin Included in the solution was stable during these 
times. The inactivation at 25°C and 37°C did not fall below 58% and 40% 
of their initial values, respectively. In addition, subsequent studies 
performed under the same conditions for periods of up to 24 hours 
revealed that D-HLT activity never decreased below these values of 59 
and 40 percent at 25°C and 37°C, respectively. Whether thlB was due to 
Incomplete removal of heparin from the HLT by heparin-Sepharose 
chromatography or that one of the two forms of HLT was more 
heparin-dependent than the other is not clear.
Inhibitor Studies
Several inhibitors of proteolytic enzymes were tested for their 
effect on human lung tryptase activity, and the resulting data are
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Figure 16. Stabilization of HLT by heparin. HLT (0.39 
micromolar) was incubated with increasing concentrations of heparin 
up to 7.0 micromolar. Fre-incubatlons were carried out for 24 hrs 
at 25°C In 0.1 molar HEPES, pH 7.5. Assays were performed using 
the substrate Z-Lys-SBzl.
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TABLE V
Controls Performed With Heparin Stabilization Studies
Assay Conditions X  Activity
D-HLT + HEPES (assayed Immediately) 100
D-HLT + HEPES + 40 uM Heparin,
total Incubation for 1.0 hr 100
D-HLT + HEPES + 40 pM Heparin added
after 30 min, total incubation 1.0 hr 81
D-HLT + HEPES, total incubation 1.0 hr 42
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Figure 17. Inactivation of D-HLT and stabilization with 
heparin. D-HLT (0.39 micromolar) was incubated with and without
7.0 micromolar heparin in 0.1 M  HEPES, pH 7.5 for the indicated 
time periods. Assays were performed using the substrates 
Z-Lys-SBzl,
£  60
# 40-
Time Onto)
O
f
^  25* C with Heparin (7.0;iM ) 
© 37* C with Heparin (7 .0  jjM)
*2 5 *0  (No Heparin) '
*3 7 *0  (No Heparin)
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presented in Table VI. HLT was inactivated by several inhibitors of 
trypsin: DIPF, TLCK, benzamidine, antipain and leupeptin. However, 
human serum which contains several trypsin inhibitors, as well as pure 
alpha-l-PI and alpha-2-macroglobulin, failed to inhibit In assays using 
either Bz-Arg-NA or azocaseln. In addition, proteinase nexin I (PN-I), 
a cell secreted serine proteinase inhibitor, failed to inhibit HLT even 
when assay mixtures contained large excesses of PN-I. Neither of the 
metal ion chelators caused appreciable inactivation. Cysteine which 
activates thiol proteinases, and pCMB, an inhibitor of such enzymes, 
were also Ineffectual. Calcium, an activator of some thiol proteinases, 
produced a 65% reduction in activity. Ovolnhlbitor was the best protein 
inhibitor of human lung tryptase, causing a 50% reduction in activity.
Proteolysis of Fibronectin 
Fibronectln obtained from the last step of purification 
demonstrated several lower molecular weight contaminants which were not 
removed for the digestion Btudles (Fig. 18). Electrophoretic analysis 
revealed that the fibronectin prepared in our laboratory was of equal 
quality to commercial preparations. Lane B of Figure 19 contained 
commercial fibronectin, and it demonstrated several minor contaminants. 
These contaminants were apparently due to proteolytic digestion of the
440,000 dalton protein. H-HLT digested native fibronectin into what 
appeared to be four major bands, but D-HLT did not cleave the protein to 
any significant degree. This is probably due to the instability of 
D-HLT during incubation and further substantiates the role of heparin in 
relation to the activity of the enzyme.
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TABLE VI
Effect of Synthetic and Natural Inhibitors on HLT.
INHIBITOR
PRE-INCUBATION
CONCENTRATION X ACTIVITY*
None 0 100
DIPF 2 mM 0
TLCK 2 mM 7.9
TPCK 2 mM 70.4
Benzamidine 2 mM 4.5
EDTA 2 mM 87.5
1,10-phenanthroline 2 mM 80.9
p-CHB 2 mM 86.8
Cys 2 mM 95.7
Ca+2 20 mM 35.1
Alpha-1-PI 0.1 mg/ml 100.5
Aft
Alpha-2-macroglobulin 0.1 mg/ml 100
Bronchial Inhibitor 0.1 mg/ml 77.2
Human Plasma (EDTA) 2 % 62.1
Human Plasma (Heparin) 2% 99.9
Trasylol 0.1 mg/ml 84.9
Ovoinhibitor 0.1 mg/ml 51.3
Soybean Trypsin Inhibitor 0.1 mg/ml 100.5
A
Assays performed using Bz-Arg-NA 
A A
Alpha-2-macroglobulin Inhibition was assayed using azocasein as the 
substrate
Effect of Synthetic
TABLE VI 
(Cont'd.)
and Natural Inhibitors
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on HLT.
INHIBITOR
PRE-INCUBATION
CONCENTRATION X ACTIVITY*
Lima Bean Inhibitor 0*1 mg/ml 103,0
Ovomucoid 0.1 mg/ml 82.5
Antipain 0.1 mg/ml 0
Chymostatin 0.1 mg/ml 93.7
Elastinal 0.1 mg/ml 97.1
Leupeptin 0.1 mg/ml 0.9
Pepstatin 0.1 mg/ml 96.A
Phosphoramldon 0.1 mg/ml 93.2
Assays performed using Bz-Arg-NA
ft ft
Alpha-2-macroglobulin inhibition was assayed using azocasein as the 
substrate
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Figure 18. SDS polyacrylamide gel electrophoresis (6Z gels) 
of selected fractions from the purification of fibronectin.
Samples were reduced with DTI prior to electrophoresis. Arrow — ♦ 
indicate fibronectin at M r 220,000. Gels were stained using 
Coomassle blue in methanol, water and acetic acid 5:5:1. Thirty ug 
of protein was added to each well.
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Figure 19. SDS electrophoresis of fibronectln and digestion 
products. Lane A contains myosin (200,000). Lane B contains 
commercial fibronectln. Lane C, D and E contain H-HLT:fibronectln 
1:10, 1:20 and 1:40 respectively. Lane F, G and F contain the same 
ratio of D-HLT:fibronectln. Gels are 62 SDS polyacrylamide and 
samples were reduced. The standard in A is unreduced.
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Immunodiffusion
Two forms of human lung tryptase were compared by immunodiffusion 
of each enzyme form from Che front of the cellulose phosphate peak and 
the back side of the peak against antlsera raised against a mixture of 
forms (Fig. 20). A  precipitin arc Indicating Identity was obtained.
The predominant form in well A was the 31,600 species while well E
contained predominantly the 30,900 Mr species.
Enzyme Kinetics
The K , V___ and k„-. for H-HLT using the substrates Z-Lys-SBzl and 
m  max cat J
Z-Arg-SBzl were determined. Tryptase apparently has a preference for 
the Arg containing substrate, since the k for the Arg substrate was
C a t
610/sec and for the Lys substituted material was 210/sec. H-HLT used to 
determine these kinetic parameters was judged to be 43Z active by 
titration with MUG-B. The results of all of the kinetic studies are 
indicated in Figure 21. Data obtained by UBing Eaddle-Hostee or Haynes 
plots were essentially the same as with the Llneweaver-Burke plots.
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Figure 20. Ouchterlony reaction with antl-HLT vs. selected 
fractions from active peak off cellulose phosphate. Center well 
contained rabbit antisera to HLT and wells A  to £ were loaded with 
10 mlcrollters each of fractions 75, 60, 85, 90 and 95 respectively 
(see Fig. 9)
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Figure 21. Lineweaver-Burke plots for KLT using the 
substrates Z-Lys-SBzl and Z-Arg-SBzl. Assays were performed at 
25°C in the HEPES buffer pH 7.5 as described in Methods. Inserts 
contain essential kinetic data.
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CHAPTER 5 
DISCUSSION
Nomenclature
The names chosen for tissue protelnases often vary and can cause 
considerable confusion. Initially most of these enzymes were called 
cathepslns, but additional Information on their properties made this 
term somewhat obsolete. Tissue derived neutral serine protelnases with 
trypsin-like specificity have been called tryptase, while chymase has 
been used for chymotrypsin-like enzymes. Although we have called the 
enzyme in this study human lung tryptase, present data indicate that 
human lung mast cell tryptase may be a more appropriate name. Better 
terminology will probably result from future studies on the enzyme's 
cellular location and natural substrate specificity.
Purification
k
The isolation of HLT by the method described is superior to that 
outlined by Schwartz et al. (1981a) for several reasons. It is less 
complicated, employs a more available source, has higher yields and 
provides partial separation of the two enzyme forms. The purification 
of mast cells for enzyme extraction by previous methods is an involved 
process requiring considerable time, also the tissue used for such mast 
cell preparations must be obtained fresh from surgery. This presents an 
inconvenience, and due to the amount of tissue available, yields are 
much lower using the previously described procedure.
67
68
The use of a chloroform extraction following the 2,0 M  NaCl 
solubilization of the enzyme may eventually replace the ammonium sulfate 
fractionation and chromatography on octyl-Sepharose. Initial studies 
using chloroform extraction suggest that it will simplify the process 
and raise yields to about 90%. There was a small amount of contaminant 
noted following cellulose phosphate chromatography when using chloroform 
extraction, but this should be a minor problem compared to the losses 
incurred with octyl-Sepharose chromatography.
The cellulose phosphate chromatography with subsequent elution by 
heparin gradient is an extremely powerful tool in the enzyme 
purification procedure. Nearly a 230-fold purification Is realized 
through the use of this chromatography matrix. In excess of 1,0 gram of 
contaminating protein does not adhere to the column during loading, and 
elution with a porcine heparin gradient is both convenient and specific 
for the removal of HLT. Furthermore, elution with heparin provides a 
method whereby HLT is immediately stabilized. The H-HLT can be pooled 
and frozen for extended periods at -20°C without significant loss of 
activity.
The specific activity of purified HLT w s b  101 using the trypsin 
substrate called TAMe. This compared favorably to specific activities 
of 78 and 98 obtained by Schwartz et al, (1981a). These authors also 
reported only 38% activity In the enzyme following purification, based
3
on [ H]-DIPF incorporation. Similar studies with HLT from our 
laboratory revealed 69% activity. Using active site titration with the 
substrate MUG-B, we judged our preparation to be 58% and 43% active for 
separate preparations. That our enzyme should be more active can be
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explained by the fact that the heparin from the porcine heparin gradient 
stabilizes the enzyme. The purification scheme of Schwartz et al. 
(1981a) Involves the use of heparln-Sepharose chromatography, and this 
produces deheparinized HLT which Is rapidly Inactivated at room 
temperature.
Attempts to use anti-HLT affinity chromatography (data not shown) 
were largely unsuccessful; however, antibody affinity columns were not 
employed after the role of heparin In the purification was elucidated. 
Preliminary studies revealed that nearly 100% of the activity applied to 
the column would bind to the affinity matrix, but the harshness of the 
elution procedure would not allow an acceptable quantity of active 
enzyme to be eluted. We were able to remove a small amount of activity 
from antl-HLT-Sepharose using 3.0 M sodium thlocyanate in 5 mM phosphate 
buffer, pH 7.0. Considerable activity was lost, but whether this was 
due to the absence of heparin or to the concentration of NaCNS was never 
established. Tests were performed which demonstrated a decrease in 
activity of HLT with increasing concentrations of NaCNS, and control 
levels remained at 100%. However, since no heparin was added to the 
elution, it is difficult to say if the omission of the acid 
mucopolysaccharide may have resulted in a loss of activity. The use of 
antibody affinity chromatography in the purification of HLT should be 
investigated again in light of what we know concerning the enzyme's 
dependency on heparin.
Several buffering systems were investigated in conjunction with HLT 
in hopes that the best conditions possible might be maintained during 
purification and characterization. The 10 mM MES, pH 6.1, 0.02% sodium
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azide with at least 0.3 H  NaCl provides the best condition for isolation 
and storage of the enzyme. Either 0.1 M  HEPES, pH 7.5 or 0.1 M 
Tris-HCl, pH 8.0, are suitable buffers to be employed while monitoring 
activity . Assays performed on material stored for 4.0 hr at 37aC 
showed that storage in MES buffer yielded between 15 and 252 more 
activity than enzyme stored in MOPS, TRIS, or NaH2P0^.
The tryptaseB of human tissues may all be of mast cell origin 
(Tanaka et al., 1983). Whether the same or similar purification 
procedure could be used to isolate tryptase from other sources would be 
of interest. At any rate, the use of whole tissue obtained at autopsy 
in preference to purified mast cell preparations has yielded more enzyme 
and lacks the inconvenience of obtaining fresh tissue from surgery.
This purification procedure has been performed approximately 12 
times with similar results. Although the amounts of enzyme found varied 
only slightly, one lung yielded 10 times the normal level of activity. 
The reason for this increase could not be explained.
Amino Acid Analysis 
Performing the amino a d d  analysis made it possible to compare the 
tryptase from whole human lung with that reported by Schwartz et al. 
(1981a), and it is clear from the data that the two enzymes are the 
same. The data that we provide are more accurate, because we were able 
to analyze samples hydrolyzed for various tlmeB and apply better methods 
for the analysis of cysteine and tryptophan. HLT did not appear to be 
related to human pancreatic trypsin which supports the suggestion of 
Woodbury et al. (1981) that the mammalian granulocyte serine protelnases 
form an evolutlonarily distinct class of serine protelnases. The 280
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nanometer extinction coefficient of 28.1 for a IX solution may seem 
high, but this value is consistent with a high tryptophan content <9 
residues/mol.)
Molecular Weight and Quarternary Structure 
Apparent molecular weight values estimated by gel filtration and 
SDS polyacrylamide gel electrohporesls were slightly lower than reported 
by Schwartz et al. (1981a). Three determinations of molecular weight in 
our laboratory revealed a of 135,000 daltons. The possibility that
HLT exists as a tetramer is suggested by the separation of two forms 
with M r - 30.9 and 31.6 kd. The partial separation of the two subunit 
forms on cellulose phosphate suggests the existence of two different 
tetramers, one containing small subunits and one large subunits. Gel 
filtration separation of two tetramers with an difference of 2800 
would be very difficult, explaining the observation of only one peak on 
gel filtration. Another explanation of these data is that the tetramer 
is an artifact resulting from the self-association of monomeric enzyme 
in 1.0 M NaCl. Since increasing amounts of NaCl reduce the activity of 
the enzyme, such an association seems possible. Gel filtration studies 
in low salt were not possible, because the enzyme binds to glass and 
plastics in the absence of salt. Lastly, there may be two species of 
mast cells in the humans similar to the "typical" and "atypical" mast 
cells of rats (Woodbury et al., 1981). Each of these mast cell types 
may contain a different species of tryptase just as the rat has two 
different chymases (KMCP I and RMCP II). Since lung contains both 
connective and mucosal tissue, the two human lung tryptase forms may be 
products of different cell types, making this an attractive explanation.
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Inhibition
Inhibition studies clearly prove that HLT is a trypsin-like serine 
proteinase. Interestingly, whole plasma, pure alpha-l-proteinase 
inhibitor, and pure alpha-2-macroglobulin all failed to inhibit HLT. 
These data contradict the conclusion of Benitez-Briblesca et al. (1973), 
who found alpha-l-proteinase Inhibitor associated with mast cells and 
proposed regulation of mast cell tryptase by this inhibitor. The 
failure of plasma and pure alpha-2-macroglobulin to inhibit HLT suggests 
that the enzyme may be too large to be "trapped" by
alpha-2-macroglobulln (Barrett and Starkey, 1973). These findings pose 
a question concerning the regulation of HLT activity. Although 
subcellular location of intracellular inhibitors may serve to control 
its activity within the cell, there seems to be no vascular Inhibitor 
for controlling HLT, which has been shown to be released upon 
anaphylatic degranulation of mast cells (Schwartz et al., 1981b). Thus, 
it would appear that extracellular HLT may be free to attack tissue 
proteins or hydrolyze other substrates following mast cell 
degranulation.
Effects of HaCl Concentration on HLT 
One distinguishing feature of HLT is decreased activity with 
increasing NaCl concentration, an effect also observed with a proteinase 
from human uterine cervix (Ito et al., 1980). In this respect HLT seems 
quite different from the rat mast cell chymases (Woodbury et al., 1981). 
Also, other protelnases such as the elastase from the granule of the 
polymorphonuclear leukocyte are assayed in buffers containing 1,0 M  NaCl 
(Barrett, 1981).
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The Role of Heparin
HLT's affinity for heparin not only provides a convenient tool for 
purification of the enzyme, but this association also creates an 
excellent method for stabilization of the enzyme while assaying for 
activity. While 7.0 micromolar heparin was necessary to protect and 
stabilize 0.39 micromolar HLT (nearly a 20-fold molar excess), it must 
be remembered that the concentration of heparin was calculated baaed on 
a ■ 10,000 for commercial heparin from porcine intestinal mucosa.
The same heparin sulfate is not found in humans and the molecular weight 
of heparin from different sources and species is known to be quite 
variable. Additionally, all heparin molecules do not bind to and 
activate antithrombin III and a similar situation may exist concerning 
HLT. Therefore, making any assumptions about the concentration of 
heparin involved in binding to HLT should be done with caution because 
of the problem in obtaining an exact molecular weight for heparin.
The mast cell granules are rich in heparin, and HLT has been 
localized HLT to these granules (Smith et al., 1984). It is likely that 
HLT exists in complex with the acid mucopolysaccharide in vivo. The 
present study substantiates the existence of such an association. If 
heparin is removed from purified HLT using heparin-Sepharose 
chromatography, the enzyme rapidly loses activity. Interestingly, this 
inactivation process does not go to completion. Approximately 40% of 
the enzyme activity remains even after extended incubationB. It is 
possible that one of the subunits of HLT, either the 30.9 kd or the 31.6 
kd species, may be more dependent on heparin for complete expression of 
activity. If this is true then only partial inactivation of D-HLT would
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be possible. Another reason for this might be Incomplete removal of 
heparin from H-HLT with heparin-Sepharose chromatography. In this case, 
residual heparin may be protecting the enzyme from complete 
Inactivation,
Since 1.0 M  NaCl is required to disrupt the binding of HLT to 
heparin one would expect that HLT released from degranulating mast cells 
would be bound to heparin which is released with HLT. The presence of 
heparin and the slightly acidic conditions of the mast cell granule may 
control and/or stabilize the enzyme in vivo. The complete Inactivation 
of the enzyme by heparin and pH as proposed by Schwartz and Austen 
(1984) does not seem probable, since the enzyme is not in zymogen form 
and our studies indicate that HLT is SOX active at pH 6.1 in vitro. On 
the other hand, HLT has been shown to be released upon mast cell 
degranulation (Schwartz et al., 1981b). If the enzyme is complexed with 
heparin, then it may be active on surrounding tissue. The biological 
activity of HLT is not understood. There is some evidence to support 
the involvement of HLT in an Intracellular role, but an equal amount of 
information would indicate that it functions extracellularly.
The absence of zymogen forms and the histochemical evidence of 
active enzyme within the cell argue that HLT is active inside the mast 
cell. If the physiological assignment of the enzyme is Intracellular, 
then it Beems possible that HLT might function in limited or complete 
proteolysis of endocytized material. If the proteolysis is limited, the 
enzyme might serve to create smaller peptides such as chemotactic 
factors which are active in anaphylaxis. Since most endocytized 
substances migrate to the mast cell granule, it is tempting to speculate
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that HLT does have such a function. IgE Is endocytized by the mast cell 
and can be found In contact with the mast cell granule In as little as 
1.0 hr being endocytized. He have performed studies Involving the 
digestion of IgE with HLT (Smith and Johnson, 1984), but found that HLT 
did not cleave the immunoglobulin, however, It may be possible that 
proteolysis did take place and was not readily apparent due to the type 
of electrophoretic analysis which was used. The question of whether HLT 
will cleave IgE or not deserves additional attention and experiments 
designed to look specifically for small peptides should be included. It 
has been shown that following maBt cell degranulation there are two 
stages of pathology. First, the classic allergic reaction appears 
within minutes and subsides in 30-60 min. Four to eight hr later a 
second phase reaction which lasts for periods of up to 24 hr takes 
place. This has been termed late phase reaction (LFR) (Kallner and 
Lemanske, 1984). LPR presents clinically as burning, ill-defined 
erythema and swelling and may be associated with the hyperactivity seen 
in the airways during hypersensitivity.
Part of the mast cell granule matrix contains inflammatory- 
provoking activity which is contained in the high salt extracts of mast 
cell granule preparations (Tannenbaum et al., 1980). The Inflammatory 
factor of anaphylaxis (IF-A) is a 1400 dalton peptide (Oertel et al., 
1980). HLT could be responsible for generating such a peptide from a 
larger precursor.
Heparinized HLT is capable of digesting flbronectln, whereas HLT 
with heparin removed Is unable to cause significant proteolysis of the 
protein. This not only confirms heparin's involvement with HLT, but
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also makes It tempting to speculate that degranulation of mast cells may 
release active enzyme capable of degrading surrounding tissue or 
protein. Since we have shown that HLT is not inhibited by -any known 
plasma proteinase Inhibitor* it is possible that active tryptase could 
be found within the lnterstltium and generalized or specific proteolysis 
might follow degranulation.
It has been shown that mast cells are found in increased numbers 
around new tumor sites before the In growth of new blood vessels 
(Kessler et al., 1976), and that angiogenesls can be stimulated by 
heparin (Taylor and Folkman, 1982). Interestingly, when heparin and 
cortisone are administered together blood vessel growth in new tumors 
stops (Folkman et al., 1983). The authors present an optimum heparin 
dose needed for this effect and suggest that heparin could function as 
both a promoter and inhibitor of angiogenesls. In the presence of 
cortisone only the latter function would be demonstrated. Heparin may 
be a stabilizing factor for HLT or another similar proteinase Involved 
in tumor growth, since proteolysis is an essential part of establishing 
vasculature for new tumors.
Enzyme Kinetics
In comparing HLT's activity using two thioester substrates,
Z-Lys-SBzl and Z-Arg-SBzl, it appears that the enzyme prefers the Arg
substitution. A  k „/K of 2.64 X 10^ M * sec- * makes the enzyme more 
cat m
active on this substrate than for any substrate thus far reported.
Tanaka et al., (1983) tested 17 amino acid dipeptide thlolesters and 14
tripeptide 4-nltroanllide as substrates HLT. The authors reported
2 5
k ^/K ranges from 10 to 10 , but these assays were performed on HLT 
cat ra
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devoid of protecting levels of heparin. It Is likely that the values
quoted are considerably lover than what they actually would have been if
H-HLT had been used. For this reason a k - 610/sec and k ./K In
cat cat in
7
the range of 10 may represent the most accurate kinetic data yet
reported on the tryptase from lung mast cells. The beBt substrate for
HLT Is probably the one recommended by Tanaka et al. (1983),
Z-Trp-Arg-SBzl. A re-investigation of K , k and k /K using thisin cat esc m
thloester substrate with H-HLT may be appropriate.
OVERVIEW
Since the discovery of the mast cell by Paul Erlich nearly 100 
years ago, efforts to assign a biological function to the cell have 
eluded researchers. For nearly 75 years investigations centering on 
this fascinating cell were based largely on Its staining 
characteristics. The discovery of the chymotrypsin-like activity of the 
rat mast cell by Gomori (1953) was a product of his work with different 
mast cell staining techniques. Subsequently, Mota and da Silva (1960) 
Isolated rat peritoneal mast cells from sensitized animals, exposed the 
cells to antigen and witnessed degranulation, and Glenner and Cohen 
(1960) found trypsin-like activity associated with human mast cells, 
launching a new era of mast cell research. The literature reflects this 
new Interest. Scores of articles have been published on the 
biochemistry of degranulation, the structure and function of the 
chemical mediators of mast cells and the possible function of this cell.
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The work presented here offers a significant contribution to the 
understanding of the biochemistry of the mast cell. We have 
successfully isolated lung mast cell tryptase by a method which gives a 
superior yield to any other method used to date. This has given us the 
potential to carry out experiments on the en2yme such as a complete 
amino acid analysis, electrophoretic analysis, molecular weight 
determination, and other physical and kinetic studies.
Aside from the purification of human lung tryptase, data which are 
particularly useful in understanding mast cell function are the 
stabilization of the enzyme by heparin, the proteolytic digestion of 
flbronectin by H-HLT and the determination of k for the enzyme. In
CAC
addition, the antibody raised to HLT will be extremely valuable in the 
localization of the enzyme and in creating assays which are sensitive as 
well as specific for the measurement of HLT in tissues.
Future investigations will Involve separating the two species of 
enzyme and generating antibody to each species. This may be used to 
determine whether or not two separate species of human lung tryptase 
exist within two different mast cell types, analogous to the situation 
with RMCFI and II in rat. When the two forms are successfully 
separated, comparisons involving their inactivation and dependency on 
heparin may be completed.
Plans also include the development of an enzyme-linked 
Immunosorbent assay (ELISA) which will make it possible to monitor 
levels of HLT in various tissues. Testing serum or tissue levels for 
the presence of HLT during pathological conditions such as tumorogenesis 
and chronic Inflammatory conditions would be of special interest. These
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conditions are known to cause increases in the number of mast cells. 
Perhaps the circulating level of HLT would be increased, since there are 
no known serum inhibitors of the proteinase.
Tanaka et al. (1983) have provided extensive kinetic data on human 
lung tryptase using various substrates. These data may not be accurate, 
since the role of heparin in relation to HLT was not known at the time 
these studies were performed. Our kinetic data more accurately reflect 
the true activity of HLT. In addition, human lung tryptase may be found 
to be more closely related to the other tissue protelnases from a 
kinetic standpoint. For this reason kinetic studies using H-HLT are 
planned. The results of these studies will be very Important in 
understanding the function of the mast cell tryptase.
While flbronectin was successfully cleaved by H-HLT, extensive 
studies such as those performed by Vartio et al. (1981) using the 
chymase from rat mast cells need to be performed. A  comparison between 
digestion products from HLT proteolysis and those from chymase digestion 
can then be made. ThlB would allow some comparison between species. 
Comparison with digestion products of trypsin would also be of value.
As with any newly isolated enzyme, there are countless experiments 
which would be of value in understanding the function of human lung 
tryptase. The amount of this enzyme, (nearly one-fourth of the total 
protein of the maBt cell) tends to moke one believe that its function is 
not of minor importance in the overall activity of the mast cell. 
Hopefully, the present work has laid a firm foundation for future 
studies on the function of HLT.
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